Lammers T - Search Results

1

Clinically established biodegradable long acting injectables: An industry perspective.

Nkanga CI, Fisch A, Rad-Malekshahi M, Romic MD, Kittel B, Ullrich T, Wang J, Krause RWM, Adler S, Lammers T, Hennink WE, Ramazani F. Nkanga CI, et al. Among authors: lammers t. Adv Drug Deliv Rev. 2020 Dec;167:19-46. doi: 10.1016/j.addr.2020.11.008. Epub 2020 Nov 14. Adv Drug Deliv Rev. 2020. PMID: 33202261 Review.

2

Tumour-targeted nanomedicines: principles and practice.

Lammers T, Hennink WE, Storm G. Lammers T, et al. Br J Cancer. 2008 Aug 5;99(3):392-7. doi: 10.1038/sj.bjc.6604483. Epub 2008 Jul 22. Br J Cancer. 2008. PMID: 18648371 Free PMC article. Review.

3

Superparamagnetic iron oxide nanoparticles encapsulated in biodegradable thermosensitive polymeric micelles: toward a targeted nanomedicine suitable for image-guided drug delivery.

Talelli M, Rijcken CJ, Lammers T, Seevinck PR, Storm G, van Nostrum CF, Hennink WE. Talelli M, et al. Among authors: lammers t. Langmuir. 2009 Feb 17;25(4):2060-7. doi: 10.1021/la8036499. Langmuir. 2009. PMID: 19166276

4

Simultaneous delivery of doxorubicin and gemcitabine to tumors in vivo using prototypic polymeric drug carriers.

Lammers T, Subr V, Ulbrich K, Peschke P, Huber PE, Hennink WE, Storm G. Lammers T, et al. Biomaterials. 2009 Jul;30(20):3466-75. doi: 10.1016/j.biomaterials.2009.02.040. Epub 2009 Mar 21. Biomaterials. 2009. PMID: 19304320

5

Improving the efficacy of combined modality anticancer therapy using HPMA copolymer-based nanomedicine formulations.

Lammers T. Lammers T. Adv Drug Deliv Rev. 2010 Feb 17;62(2):203-30. doi: 10.1016/j.addr.2009.11.028. Epub 2009 Dec 4. Adv Drug Deliv Rev. 2010. PMID: 19951732 Review.

6

Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin.

Talelli M, Iman M, Varkouhi AK, Rijcken CJ, Schiffelers RM, Etrych T, Ulbrich K, van Nostrum CF, Lammers T, Storm G, Hennink WE. Talelli M, et al. Among authors: lammers t. Biomaterials. 2010 Oct;31(30):7797-804. doi: 10.1016/j.biomaterials.2010.07.005. Epub 2010 Jul 31. Biomaterials. 2010. PMID: 20673684

7

Nanotheranostics and image-guided drug delivery: current concepts and future directions.

Lammers T, Kiessling F, Hennink WE, Storm G. Lammers T, et al. Mol Pharm. 2010 Dec 6;7(6):1899-912. doi: 10.1021/mp100228v. Epub 2010 Oct 6. Mol Pharm. 2010. PMID: 20822168 Review.

8

Gene silencing activity of siRNA polyplexes based on thiolated N,N,N-trimethylated chitosan.

Varkouhi AK, Verheul RJ, Schiffelers RM, Lammers T, Storm G, Hennink WE. Varkouhi AK, et al. Among authors: lammers t. Bioconjug Chem. 2010 Dec 15;21(12):2339-46. doi: 10.1021/bc1003789. Epub 2010 Nov 4. Bioconjug Chem. 2010. PMID: 21049986

9

Gene silencing activity of siRNA polyplexes based on biodegradable polymers.

Varkouhi AK, Lammers T, Schiffelers RM, van Steenbergen MJ, Hennink WE, Storm G. Varkouhi AK, et al. Among authors: lammers t. Eur J Pharm Biopharm. 2011 Apr;77(3):450-7. doi: 10.1016/j.ejpb.2010.11.016. Epub 2010 Nov 29. Eur J Pharm Biopharm. 2011. PMID: 21118719

10

HPMA-based polymer therapeutics improve the efficacy of surgery, of radiotherapy and of chemotherapy combinations.

Lammers T, Subr V, Ulbrich K, Peschke P, Huber PE, Hennink WE, Storm G, Kiessling F. Lammers T, et al. Nanomedicine (Lond). 2010 Dec;5(10):1501-23. doi: 10.2217/nnm.10.130. Nanomedicine (Lond). 2010. PMID: 21143030

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

364 results

Search Page